Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironment

Oncology Letters

Volumn 11, Issue 2, 2016, Pages 1035-1042

  Hsu, Ya Ling ^a   Hsieh, Chia Jung ^a,b   Tsai, Eing Mei ^a   Hung, Jen Yu ^b,c   Chang, Wei An ^b,d   Hou, Ming Feng ^d   Kuo, Po Lin ^d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Didymin; Phthalate esters; Tumor microenvironment

Indexed keywords

CD14 ANTIGEN; DIDYMIN; FLAVONOID GLYCOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DIBUTYL ESTER; RANTES; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84954357211     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.4008     Document Type: Article

References (46)

1. Martino-Andrade AJ and Chahoud I: Reproductive toxicity of phthalate esters. Mol Nutr Food Res 54: 148-157, 2010.
2. Ge RS, Chen GR, Tanrikut C and Hardy MP: Phthalate ester toxicity in Leydig cells: Developmental timing and dosage considerations. Reprod Toxicol 23: 366-373, 2007.
3. López-Carrillo L, Hernández-Ramírez RU, Calafat AM, Torres-Sánchez L, Galván-Portillo M, Needham LL, Ruiz-Ramos R and Cebrián ME: Exposure to phthalates and breast cancer risk in northern Mexico. Environ Health Perspect 118: 539-544, 2010.
4. Aschengrau A, Coogan PF, Quinn M and Cashins LJ: Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: An exploratory analysis. Am J Ind Med 34: 6-14, 1998.
5. Carran M and Shaw IC: New Zealand Malayan war veterans' exposure to dibutylphthalate is associated with an increased incidence of cryptorchidism, hypospadias and breast cancer in their children. N Z Med J 125: 52-63, 2012.
6. Sprague BL, Trentham-Dietz A, Hedman CJ, Wang J, Hemming JD, Hampton JM, Buist DS, Aiello Bowles EJ, Sisney GS and Burnside ES: Circulating serum xenoestrogens and mammographic breast density. Breast Cancer Res 15: R45, 2013.
7. Katoh H, Wang D, Daikoku T, Sun H, Dey SK and Dubois RN: CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 24: 631-644, 2013.
8. Peltekova VD, Lemire M, Qazi AM, Zaidi SH, Trinh QM, Bielecki R, Rogers M, Hodgson L, Wang M, D'Souza DJ, et al: Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants. Int J Cancer 134: 2330-2341, 2014.
9. Gajewski TF, Schreiber H and Fu YX: Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14: 1014-1022, 2013.
10. Hsu YL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH and Kuo PL: Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression. J Immunol 187: 1733-1744, 2011.
11. Kuo CH, Chen KF, Chou SH, Huang YF, Wu CY, Cheng DE, Chen YW, Yang CJ, Hung JY and Huang MS: Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway. Carcinogenesis 34: 2600-2609, 2013.
12. Gonzalez RM, Daly DS, Tan R, Marks JR and Zangar RC: Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased. Cancer Epidemiol Biomarkers Prev 20:1543-1551, 2011.
13. Velasco-Velázquez M and Pestell RG: The CCL5/CCR5 axis promotes metastasis in basal breast cancer. Oncoimmunology 2: e23660, 2013.
14. Lv D, Zhang Y, Kim HJ, Zhang L and Ma X: CCL5 as a potential immunotherapeutic target in triple-negative breast cancer. Cell Mol Immunol 10: 303-310, 2013.
15. Zhang Y, Lv D, Kim HJ, Kurt RA, Bu W, Li Y and Ma X: A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Res 23: 394-408, 2013.
16. Ash SA, Valchev GI, Looney M, Ni Mhathuna A, Crowley PD, Gallagher HC and Buggy DJ: Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: Comparison with sevoflurane. Br J Anaesth 113 (Suppl 1): i14-i21, 2014.
17. Takemura H, Sakakibara H, Yamazaki S and Shimoi K: Breast cancer and flavonoids - a role in prevention. Curr Pharm Des 19: 6125-6132, 2013.
18. Donaldson MS: Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr J 3: 19, 2004.
19. Stoner GD and Mukhtar H: Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 22: 169-180, 1995.
20. Yang CS, Landau JM, Huang MT and Newmark HL: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21: 381-406, 2001.
21. Aggarwal BB and Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1421, 2006.
22. Ramos AM and Aller P: Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochem Pharmacol 75: 1912-1923, 2008.
23. Calabrò ML, Galtieri V, Cutroneo P, Tommasini S, Ficarra P and Ficarra R: Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice. J Pharm Biomed Anal 35: 349-363, 2004.
24. Finotti E and Di Majo D: Influence of solvents on the antioxidant property of flavonoids. Nahrung 47: 186-187, 2003.
25. Mouly P, Gaydou EM and Auffray A: Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J Chromatogr A 800: 171-179, 1998.
26. Ross SA, Ziska DS, Zhao K and ElSohly MA: Variance of common flavonoids by brand of grapefruit juice. Fitoterapia 71: 154-161, 2000.
27. Hung JY, Hsu YL, Ko YC, Tsai YM, Yang CJ, Huang MS and Kuo PL: Didymin, a dietary flavonoid glycoside from citrus fruits, induces Fas-mediated apoptotic pathway in human non-small-cell lung cancer cells in vitro and in vivo. Lung Cancer 68: 366-374, 2010.
28. Singhal J, Nagaprashantha LD, Vatsyayan R, Ashutosh, Awasthi S and Singhal SS: Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma. Cancer Prev Res (Phila) 5: 473-483, 2012.
29. Zeng F, Xie L, Pang X, Liu W, Nie Q and Zhang X: Complementary eoxyribonucleic acid cloning of avian G0/G1 switch gene 2, and its expression and association with production traits in chicken. Poult Sci 90: 1548-1554, 2011.
30. Bharadwaj U, Li M, Zhang R, Chen C and Yao Q: Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 67: 5479-5488, 2007.
31. Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H and Hurwitz AA: FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest 121: 1361-1372, 2011.
32. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Hsi E, Suen JL, Hung CH, Lee JN, Chai CY, Wang SC and Tsai EM: n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1. PLoS One 7: e42750, 2012.
33. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC and Tsai EM: Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J 26: 778-787, 2012.
34. Chen FP and Chien MH: Lower concentrations of phthalates induce proliferation in human breast cancer cells. Climacteric 17: 377-384, 2014.
35. Hsu YL, Tsai EM, Hou MF, Wang TN, Hung JY and Kuo PL: Obtusifolin suppresses phthalate esters-induced breast cancer bone metastasis by targeting parathyroid hormone-related protein. J Agric Food Chem 62: 11933-11940, 2014.
36. Tsai MJ, Chang WA, Huang MS and Kuo PL: Tumor microenvironment: A new treatment target for cancer. ISRN Biochem 2014: 351959, 2014.
37. Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX, Wang CY, Sun K, Jiang GC, Zhao X, Li R, et al: Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 286: 25007-25015, 2011.
38. Luo YP, Zhou H, Krueger J, Kaplan C, Liao D, Markowitz D, Liu C, Chen T, Chuang TH, Xiang R and Reisfeld RA: The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene 29: 662-673, 2010.
39. Hsu YL, Hou MF, Kuo PL, Huang YF and Tsai EM: Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene 32: 4436-4447, 2013.
40. Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, et al: Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res 72: 1092-1102, 2012.
41. Soria G, Ofri-Shahak M, Haas I, Yaal-Hahoshen N, Leider-Trejo L, Leibovich-Rivkin T, Weitzenfeld P, Meshel T, Shabtai E, Gutman M and Ben-Baruch A: Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. BMC Cancer 11: 130, 2011.
42. Borczuk AC, Papanikolaou N, Toonkel RL, Sole M, Gorenstein LA, Ginsburg ME, Sonett JR, Friedman RA and Powell CA: Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. Oncogene 27: 557-564, 2008.
43. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot LJ and Kuo PC: Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis. Carcinogenesis 32: 477-487, 2011.
44. Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, Scherag A, Hütte J, Dominas N, Lehnerdt GF, et al: Polymorphonuclear granulocytes in human head and neck cancer: Enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129: 2183-2193, 2011.
45. Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP and Pestell RG: c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 285: 8218-8226, 2010.
46. Yi EH, Lee CS, Lee JK, Lee YJ, Shin MK, Cho CH, Kang KW, Lee JW, Han W, Noh DY, et al: STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 11: 31-42, 2013.